JPRN-UMIN000000801未知2 期
A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer. - A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
Dept. of Internal Medicine(4)0 个研究点目标入组 30 人开始时间: 2007年8月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. A history of hypersensitivity reaction to drugs formulated with polysorbate 80. 2. Patients contraindicated to docetaxel, cisplatin, S-1, or G-CSF. 3. Documented or suspected infection. 4. Uncontrolled medical conditions (e.g., malignant hypertension, congestive heart failure, myocardial infarction in previous 3 months, arrhythmia requiring treatment, diabetes, interstitial pneumonia, pulmonary fibrosis). 5. Grade 2 or greater peripheral neuropathy. 6. Patients with brain metastasis 7. Patients with diarrhea. 8. Active concomitant malignancy. 9. Pregnant or lactating women and women of child bearing potential not using contraception. 10. Men with partner willing to get pregnant 11. Patients judged by the investigator as unfit to be enrolled in the study. 12. Patients already enrolled in this study.
研究者
相似试验
招募中
2 期
The Phase II Study of Docetaxel plus Nedaplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Canceron-small cell lung cancerJPRN-UMIN000004634Shiga University of Medical Science30
已完成
2 期
Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016)JPRN-UMIN000004368Thoracic Oncology Research Group47
已完成
2 期
Phase II study of the combination of docetaxel, cisplatin plus S-1(DCS) for advanced or recurrent gastric cancer(KDOG 0601)Gastric cancerJPRN-UMIN000001119Department of Gastroenterology, Kitasato University School of Medicine45
已完成
1 期
Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancergastric cancerJPRN-UMIN000011625Yokohama City University Medical Center51
进行中（未招募）
不适用
Phase II study: Treatment with the drug docetaxel and oxaliplatin for patients who have a confirmed metastatic or locally advanced cancer of the pancreas and in whom initial therapy has failed.EUCTR2005-004236-40-DEniversitätsklinikum Ulm44